Table 1.
Baseline characteristics of patients with clinical T1 stage clear cell renal cell cancers (ccRCC) (≤7-cm) included in this study.
| Clinical T1 stage ccRCC (≤7-cm) (n = 177) | |
|---|---|
| Gender, n (%) | |
| Male | 127 (71.8%) |
| Female | 50 (28.2%) |
| Age (years) | 58.5 ± 11.7 |
| BMI (kg/m2) | 24.8 ± 3.6 |
| Radical surgery, n (%) | 94 (53.1%) |
| Tumor size (cm) | 4.1 ± 1.6 |
| Fuhrman grade | |
| 1 | 8 (4.5%) |
| 2 | 79 (44.6%) |
| 3 | 81 (45.8%) |
| 4 | 9 (5.1%) |
| Invasion (perinephric/sinus fat/vascular), n (%) | 11 (6.2%) |
| Positive nodal status, n (%) | 1 (1.0%) |
| Synchronous metastasis, n (%) | 19 (10.7%) |
| Recurrences, n (%) | 23 (13.0%) |
| Cancer-specific death, n (%) | 30 (16.9%) |
| Gene expressions | |
| FOXC2 | 0.0065 ± 0.0152 |
| CLIP4 | 0.0077 ± 0.0152 |
| PBRM1 | 0.0041 ± 0.0111 |
| SETD2 | 0.0004 ± 0.0006 |
| BAP1 | 0.0002 ± 0.0005 |
| KDM5C | 0.0027 ± 0.0083 |
Data are shown as mean ± SD or number of subjects (%)
BMI, body mass index